Copyright © 1991 by the European Society of Cardiology.
© 1991 The European Society of Cardiology
Geographical variation of mortality from cardiovascular diseases
The Project ‘Myocardial Infarction in mid-Sweden’
RDSUDDUppsala University, Department of Family Medicine, Uppsala and Centre for Public Health Research Karlstad, Sweden
Received 6 June 1989; revised 12 March 1990; .
Correspondence to. Christina Nerbrand. MD, Centre for Public Health Research, Landstinget i Varmland, S-651 82 Karlstad, Sweden.
Abstract
In this study, the geographical variation of the mortality rate in mid-Sweden was studied. Data on mortality from all causes and mortality from cardiovascular diseases, cerebrovascular diseases, ischaemic heart disease (IHD) and non-cardiovascular diseases for men and women 45–74 years of age living in 76 communities in mid-Sweden were obtained from the National Bureau of Statistics. After age standardization, the rates for mortality from all causes and cardiovascular mortality were substantially higher in the Westernmost communities compared with those in the East, whereas for non-cardiovascular mortality there were no systematic differences. The county with the higher rate for IHD had a 60% higher rate for men aged 45–64 years and a 53% higher rate for women aged 45–64 years than the county with the lowest rate. The corresponding excess mortality rates from stroke were 73% for men aged 45–74 and 46% for women aged 45–74 years.
The cause of this variation is not known. It is not due to the confounding effect of different age distributions in the communities, differences in the registration of causes of death, or differences in case fatality rate.
Key Words: Cardiovascular disease • ischaemic heart disease • mortality • epidemiology
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. A. Gintant, Z. Su, R. L. Martin, and B. F. Cox Utility of hERG Assays as Surrogate Markers of Delayed Cardiac Repolarization and QT Safety Toxicol Pathol, January 1, 2006; 34(1): 81 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Splawski, K. W. Timothy, N. Decher, P. Kumar, F. B. Sachse, A. H. Beggs, M. C. Sanguinetti, and M. T. Keating Inaugural Article: Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations PNAS, June 7, 2005; 102(23): 8089 - 8096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Roden An Underrecognized Challenge in Evaluating Postmarketing Drug Safety Circulation, January 25, 2005; 111(3): 246 - 248. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Sanguinetti and P. B. Bennett Antiarrhythmic Drug Target Choices and Screening Circ. Res., September 19, 2003; 93(6): 491 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D A Lawlor, C Bedford, M Taylor, and S Ebrahim Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study J. Epidemiol. Community Health, February 1, 2003; 57(2): 134 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Tyden, O Hansen, G Engstrom, B Hedblad, and L Janzon Myocardial infarction in an urban population: worse long term prognosis for patients from less affluent residential areas J. Epidemiol. Community Health, October 1, 2002; 56(10): 785 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M Hondeghem, K. Dujardin, and F. De Clerck Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia Cardiovasc Res, May 1, 2001; 50(2): 345 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G.A. Volders, M. A. Vos, B. Szabo, K. R. Sipido, S.H.M. de Groot, A. P.M. Gorgels, H. J.J. Wellens, and R. Lazzara Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts Cardiovasc Res, June 1, 2000; 46(3): 376 - 392. [Full Text] [PDF]
|
|
|
|
|
|
L. Eckardt, W. Haverkamp, M. Borggrefe, and G. Breithardt Experimental models of torsade de pointes Cardiovasc Res, July 1, 1998; 39(1): 178 - 193. [Abstract] [Full Text] [PDF]
|
|